Fluoropharma Medical Stock Fundamentals
| FPMI Stock | USD 0.0001 0.00 0.00% |
Fluoropharma Medical fundamentals help investors to digest information that contributes to Fluoropharma Medical's financial success or failures. It also enables traders to predict the movement of Fluoropharma Pink Sheet. The fundamental analysis module provides a way to measure Fluoropharma Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Fluoropharma Medical pink sheet.
Fluoropharma |
Fluoropharma Medical Company Shares Outstanding Analysis
Fluoropharma Medical's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Fluoropharma Medical Shares Outstanding | 34.26 M |
Most of Fluoropharma Medical's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Fluoropharma Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Fluoropharma Medical has 34.26 M of shares currently outstending. This is 81.02% lower than that of the Biotechnology sector and 67.94% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 94.01% higher than that of the company.
Fluoropharma Medical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Fluoropharma Medical's current stock value. Our valuation model uses many indicators to compare Fluoropharma Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Fluoropharma Medical competition to find correlations between indicators driving Fluoropharma Medical's intrinsic value. More Info.Fluoropharma Medical is rated below average in return on asset category among its peers. It is rated below average in current valuation category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Fluoropharma Medical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Fluoropharma Medical's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Fluoropharma Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Fluoropharma Medical's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Fluoropharma Medical could also be used in its relative valuation, which is a method of valuing Fluoropharma Medical by comparing valuation metrics of similar companies.Fluoropharma Medical is currently under evaluation in shares outstanding category among its peers.
Fluoropharma Fundamentals
| Return On Asset | -2.35 | |||
| Current Valuation | 9.23 M | |||
| Shares Outstanding | 34.26 M | |||
| Shares Owned By Institutions | 0.34 % | |||
| Price To Earning | (0.39) X | |||
| Price To Book | 17.76 X | |||
| EBITDA | (2.16 M) | |||
| Net Income | (2.05 M) | |||
| Cash And Equivalents | 24.72 K | |||
| Total Debt | 5.82 M | |||
| Debt To Equity | 0.07 % | |||
| Book Value Per Share | (0.30) X | |||
| Cash Flow From Operations | (880.12 K) | |||
| Earnings Per Share | (0.08) X | |||
| Target Price | 2.5 | |||
| Beta | -59.92 | |||
| Market Capitalization | 3.43 M | |||
| Total Asset | 334.76 K | |||
| Retained Earnings | (34.16 M) | |||
| Working Capital | (10.23 M) | |||
| Current Asset | 89 K | |||
| Current Liabilities | 10.32 M | |||
| Net Asset | 334.76 K |
About Fluoropharma Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Fluoropharma Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Fluoropharma Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Fluoropharma Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.FluoroPharma Medical, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of molecular imaging pharmaceuticals with initial applications in the area of cardiology in the United States. FluoroPharma Medical, Inc. was founded in 2003 and is headquartered in Montclair, New Jersey. Fluoropharma Medical operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 4 people.
Currently Active Assets on Macroaxis
Other Information on Investing in Fluoropharma Pink Sheet
Fluoropharma Medical financial ratios help investors to determine whether Fluoropharma Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Fluoropharma with respect to the benefits of owning Fluoropharma Medical security.